Acupuncture for the Treatment of Major Depressive Disorder: A Randomized Controlled Trial

This randomized controlled trial investigated the efficacy of electroacupuncture in the treatment of major depression, a condition that affects up to 20% of the adult population and frequently shows resistance to conventional treatments. With more than 50% of patients not tolerating or not responding adequately to antidepressants, complementary therapies such as acupuncture have generated increasing interest. The research was conducted from March 2004 to May 2007 at the University of Pittsburgh, with 53 participants aged 18 to 80 years diagnosed with mild to moderate major depression. Participants were randomized to two groups: active electroacupuncture (28 people) using GV-20 and Yintang with 2 Hz electrical stimulation, and control acupuncture (25 people) with needling at non-meridian points without electrical stimulation.

All participants discontinued psychotropic medications before the study and received 12 sessions of 30 minutes over 6-8 weeks. The primary outcome was measured by the Hamilton Depression Rating Scale (HDRS), administered weekly by blinded assessors. The results were surprising: both groups showed significant and equivalent improvement in depressive symptoms. The electroacupuncture group had a mean reduction of 6.6 points on the HDRS (37.5% relative improvement), while the control group showed a reduction of 7.6 points (41.3% improvement).

There was no statistically significant difference between the groups (p = 0.56). Clinical response rates were also similar: 40% in electroacupuncture versus 44% in control. Both treatments were well tolerated, with no serious adverse events. Safety was similar between groups, measured by the UKU scale.

There were no significant differences in functional improvement, anxiety symptoms, or sleep disturbances between the groups. The researchers interpreted these results considering several methodological limitations. First, the control group may not have been truly inert, since in traditional Chinese medicine the entire scalp region is considered a therapeutic microsystem. Second, the standardized protocol with only two points may have been insufficient compared with the individualized clinical practice of acupuncture.

Third, the dosage may have been inadequate compared with Chinese studies that used more intensive protocols. The clinical implications suggest that both specific and non-specific point stimulation may produce therapeutic benefits in depression, possibly through common neurobiological mechanisms. This finding aligns with other North American studies that showed similar results between active and control acupuncture, contrasting with Chinese studies that demonstrated superiority of acupuncture over medications. The study contributes to the understanding that the effects of acupuncture on depression may be more complex than initially presumed, involving both specific and non-specific components.

Future research could explore three-group designs, including individualized protocols according to traditional Chinese medicine, controls with non-penetrating needles, and a greater number of points. The tolerability demonstrated suggests that acupuncture may be a safe option for patients who do not tolerate or prefer to avoid antidepressant medications, although more studies are needed to establish optimized protocols.